Whitfield Michael L, George Lacy K, Grant Gavin D, Perou Charles M
Department of Genetics and Norris Cotton Cancer Center, Dartmouth Medical School, 7400 Remsen, Hanover, New Hampshire 03755, USA.
Nat Rev Cancer. 2006 Feb;6(2):99-106. doi: 10.1038/nrc1802.
When normal tissue and tumour samples are compared by microarray analysis, the biggest differences most often occur in the expression levels of genes that control cell proliferation. However, this difference is detected whenever mRNA samples that are taken from two cell populations with different proliferation rates are compared. Although the exact genes that comprise this 'proliferation signature' often differ, they are almost always genes that are involved in the fundamental process of cell proliferation. Can the proliferation signature be used to improve our understanding of the cell cycle and cancer pathogenesis, as well as being used as a biomarker for cancer diagnosis and prognosis?
当通过微阵列分析比较正常组织和肿瘤样本时,最大的差异通常出现在控制细胞增殖的基因的表达水平上。然而,每当比较从具有不同增殖率的两个细胞群体中获取的mRNA样本时,都会检测到这种差异。尽管构成这种“增殖特征”的确切基因通常不同,但它们几乎总是参与细胞增殖基本过程的基因。这种增殖特征能否用于增进我们对细胞周期和癌症发病机制的理解,以及用作癌症诊断和预后的生物标志物?